Cargando…
EIF5A2 Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Growth by Modulating TGF-β Signals
Anaplastic thyroid carcinoma (ATC) is resistant to standard therapies and has no effective treatment. Eukaryotic translation initiation factor 5A2 (EIF5A2) has shown to be upregulated in many malignant tumors and proposed to be a critical gene involved in tumor metastasis. In this study, we aimed to...
Autores principales: | Hao, Fengyun, Zhu, Qingli, Lu, Lingwei, Sun, Shukai, Huang, Yichuan, Zhang, Jinna, Liu, Zhaohui, Miao, Yuanqing, Jiao, Xuelong, Chen, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851513/ https://www.ncbi.nlm.nih.gov/pubmed/32138807 http://dx.doi.org/10.3727/096504020X15834065061807 |
Ejemplares similares
-
Epigallocatechin gallate (EGCG) suppresses epithelial-Mesenchymal transition (EMT) and invasion in anaplastic thyroid carcinoma cells through blocking of TGF-β1/Smad signaling pathways
por: Li, Tingting, et al.
Publicado: (2019) -
miR-211 alleviates ischaemia/reperfusion-induced kidney injury by targeting TGFβR2/TGF-β/SMAD3 pathway
por: Shang, Jinchun, et al.
Publicado: (2020) -
Expression of long non-coding RNA H19 predicts distant metastasis in minimally invasive follicular thyroid carcinoma
por: Dai, Yan, et al.
Publicado: (2019) -
Targeting Transforming Growth Factor-Beta1 (TGF-β1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NF-κB-PUMA Signaling
por: Yin, Qiang, et al.
Publicado: (2016) -
Retracted: Targeting Transforming Growth Factor-Beta1 (TGF-β1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NFκB-PUMA Signaling
por: Yin, Qiang, et al.
Publicado: (2022)